The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Subcutaneous Immunoglobulins-Global Market Insights and Sales Trends 2025
Synopsis
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
The global Subcutaneous Immunoglobulins market size is expected to reach US$ 9807.2 million by 2029, growing at a CAGR of 12.1% from 2023 to 2029. The market is mainly driven by the significant applications of Subcutaneous Immunoglobulins in various end use industries. The expanding demands from the Primary Immunodeficiency, Secondary Immunodeficiency and Others,, are propelling Subcutaneous Immunoglobulins market. 0.1, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 0.2 segment is estimated at % CAGR for the next seven-year period.
In United States, Subcutaneous Immunoglobulins key players include Shire (Baxalta), Grifols, etc. Global top two manufacturers hold a share over 90%.
South is the largest market, with a share about 35%, followed by West, and Northeast, both have a share about 45 percent.
In terms of product, 10% Purity is the largest segment, with a share over 75%. And in terms of application, the largest application is Primary Immunodeficiency, followed by Secondary Immunodeficiency, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Purity, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Subcutaneous Immunoglobulins, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Subcutaneous Immunoglobulins market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Subcutaneous Immunoglobulins market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Subcutaneous Immunoglobulins sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Subcutaneous Immunoglobulins covered in this report include Shire (Baxalta), Grifols and CSL, etc.
The global Subcutaneous Immunoglobulins market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Shire (Baxalta)
Grifols
CSL
Global Subcutaneous Immunoglobulins market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Subcutaneous Immunoglobulins market, Segment by Purity:
0.1
0.2
Global Subcutaneous Immunoglobulins market, by Application
Primary Immunodeficiency
Secondary Immunodeficiency
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Purity, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Subcutaneous Immunoglobulins manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Subcutaneous Immunoglobulins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
The global Subcutaneous Immunoglobulins market size is expected to reach US$ 9807.2 million by 2029, growing at a CAGR of 12.1% from 2023 to 2029. The market is mainly driven by the significant applications of Subcutaneous Immunoglobulins in various end use industries. The expanding demands from the Primary Immunodeficiency, Secondary Immunodeficiency and Others,, are propelling Subcutaneous Immunoglobulins market. 0.1, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 0.2 segment is estimated at % CAGR for the next seven-year period.
In United States, Subcutaneous Immunoglobulins key players include Shire (Baxalta), Grifols, etc. Global top two manufacturers hold a share over 90%.
South is the largest market, with a share about 35%, followed by West, and Northeast, both have a share about 45 percent.
In terms of product, 10% Purity is the largest segment, with a share over 75%. And in terms of application, the largest application is Primary Immunodeficiency, followed by Secondary Immunodeficiency, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Purity, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Subcutaneous Immunoglobulins, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Subcutaneous Immunoglobulins market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Subcutaneous Immunoglobulins market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Subcutaneous Immunoglobulins sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Subcutaneous Immunoglobulins covered in this report include Shire (Baxalta), Grifols and CSL, etc.
The global Subcutaneous Immunoglobulins market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Shire (Baxalta)
Grifols
CSL
Global Subcutaneous Immunoglobulins market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Subcutaneous Immunoglobulins market, Segment by Purity:
0.1
0.2
Global Subcutaneous Immunoglobulins market, by Application
Primary Immunodeficiency
Secondary Immunodeficiency
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Purity, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Subcutaneous Immunoglobulins manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Subcutaneous Immunoglobulins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Subcutaneous Immunoglobulins Market Overview
1.1 Subcutaneous Immunoglobulins Product Overview
1.2 Subcutaneous Immunoglobulins Market Segment by Purity
1.2.1 0.1
1.2.2 0.2
1.3 Global Subcutaneous Immunoglobulins Market Size by Purity
1.3.1 Global Subcutaneous Immunoglobulins Market Size Overview by Purity (2018-2029)
1.3.2 Global Subcutaneous Immunoglobulins Historic Market Size Review by Purity (2018-2023)
1.3.3 Global Subcutaneous Immunoglobulins Forecasted Market Size by Purity (2024-2029)
1.4 Key Regions Market Size Segment by Purity
1.4.1 North America Subcutaneous Immunoglobulins Sales Breakdown by Purity (2018-2023)
1.4.2 Europe Subcutaneous Immunoglobulins Sales Breakdown by Purity (2018-2023)
1.4.3 Asia-Pacific Subcutaneous Immunoglobulins Sales Breakdown by Purity (2018-2023)
1.4.4 Latin America Subcutaneous Immunoglobulins Sales Breakdown by Purity (2018-2023)
1.4.5 Middle East and Africa Subcutaneous Immunoglobulins Sales Breakdown by Purity (2018-2023)
2 Global Subcutaneous Immunoglobulins Market Competition by Company
2.1 Global Top Players by Subcutaneous Immunoglobulins Sales (2018-2023)
2.2 Global Top Players by Subcutaneous Immunoglobulins Revenue (2018-2023)
2.3 Global Top Players by Subcutaneous Immunoglobulins Price (2018-2023)
2.4 Global Top Manufacturers Subcutaneous Immunoglobulins Manufacturing Base Distribution, Sales Area, Product Type
2.5 Subcutaneous Immunoglobulins Market Competitive Situation and Trends
2.5.1 Subcutaneous Immunoglobulins Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Subcutaneous Immunoglobulins Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Subcutaneous Immunoglobulins as of 2022)
2.7 Date of Key Manufacturers Enter into Subcutaneous Immunoglobulins Market
2.8 Key Manufacturers Subcutaneous Immunoglobulins Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Subcutaneous Immunoglobulins Status and Outlook by Region
3.1 Global Subcutaneous Immunoglobulins Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Subcutaneous Immunoglobulins Historic Market Size by Region
3.2.1 Global Subcutaneous Immunoglobulins Sales in Volume by Region (2018-2023)
3.2.2 Global Subcutaneous Immunoglobulins Sales in Value by Region (2018-2023)
3.2.3 Global Subcutaneous Immunoglobulins Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Subcutaneous Immunoglobulins Forecasted Market Size by Region
3.3.1 Global Subcutaneous Immunoglobulins Sales in Volume by Region (2024-2029)
3.3.2 Global Subcutaneous Immunoglobulins Sales in Value by Region (2024-2029)
3.3.3 Global Subcutaneous Immunoglobulins Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Subcutaneous Immunoglobulins by Application
4.1 Subcutaneous Immunoglobulins Market Segment by Application
4.1.1 Primary Immunodeficiency
4.1.2 Secondary Immunodeficiency
4.1.3 Others
4.2 Global Subcutaneous Immunoglobulins Market Size by Application
4.2.1 Global Subcutaneous Immunoglobulins Market Size Overview by Application (2018-2029)
4.2.2 Global Subcutaneous Immunoglobulins Historic Market Size Review by Application (2018-2023)
4.2.3 Global Subcutaneous Immunoglobulins Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Subcutaneous Immunoglobulins Sales Breakdown by Application (2018-2023)
4.3.2 Europe Subcutaneous Immunoglobulins Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Subcutaneous Immunoglobulins Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Subcutaneous Immunoglobulins Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Subcutaneous Immunoglobulins Sales Breakdown by Application (2018-2023)
5 North America Subcutaneous Immunoglobulins by Country
5.1 North America Subcutaneous Immunoglobulins Historic Market Size by Country
5.1.1 North America Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Subcutaneous Immunoglobulins Sales in Volume by Country (2018-2023)
5.1.3 North America Subcutaneous Immunoglobulins Sales in Value by Country (2018-2023)
5.2 North America Subcutaneous Immunoglobulins Forecasted Market Size by Country
5.2.1 North America Subcutaneous Immunoglobulins Sales in Volume by Country (2024-2029)
5.2.2 North America Subcutaneous Immunoglobulins Sales in Value by Country (2024-2029)
6 Europe Subcutaneous Immunoglobulins by Country
6.1 Europe Subcutaneous Immunoglobulins Historic Market Size by Country
6.1.1 Europe Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Subcutaneous Immunoglobulins Sales in Volume by Country (2018-2023)
6.1.3 Europe Subcutaneous Immunoglobulins Sales in Value by Country (2018-2023)
6.2 Europe Subcutaneous Immunoglobulins Forecasted Market Size by Country
6.2.1 Europe Subcutaneous Immunoglobulins Sales in Volume by Country (2024-2029)
6.2.2 Europe Subcutaneous Immunoglobulins Sales in Value by Country (2024-2029)
7 Asia-Pacific Subcutaneous Immunoglobulins by Region
7.1 Asia-Pacific Subcutaneous Immunoglobulins Historic Market Size by Region
7.1.1 Asia-Pacific Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Subcutaneous Immunoglobulins Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Subcutaneous Immunoglobulins Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Subcutaneous Immunoglobulins Forecasted Market Size by Region
7.2.1 Asia-Pacific Subcutaneous Immunoglobulins Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Subcutaneous Immunoglobulins Sales in Value by Region (2024-2029)
8 Latin America Subcutaneous Immunoglobulins by Country
8.1 Latin America Subcutaneous Immunoglobulins Historic Market Size by Country
8.1.1 Latin America Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Subcutaneous Immunoglobulins Sales in Volume by Country (2018-2023)
8.1.3 Latin America Subcutaneous Immunoglobulins Sales in Value by Country (2018-2023)
8.2 Latin America Subcutaneous Immunoglobulins Forecasted Market Size by Country
8.2.1 Latin America Subcutaneous Immunoglobulins Sales in Volume by Country (2024-2029)
8.2.2 Latin America Subcutaneous Immunoglobulins Sales in Value by Country (2024-2029)
9 Middle East and Africa Subcutaneous Immunoglobulins by Country
9.1 Middle East and Africa Subcutaneous Immunoglobulins Historic Market Size by Country
9.1.1 Middle East and Africa Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Subcutaneous Immunoglobulins Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Subcutaneous Immunoglobulins Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Subcutaneous Immunoglobulins Forecasted Market Size by Country
9.2.1 Middle East and Africa Subcutaneous Immunoglobulins Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Subcutaneous Immunoglobulins Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Shire (Baxalta)
10.1.1 Shire (Baxalta) Company Information
10.1.2 Shire (Baxalta) Introduction and Business Overview
10.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Shire (Baxalta) Subcutaneous Immunoglobulins Products Offered
10.1.5 Shire (Baxalta) Recent Development
10.2 Grifols
10.2.1 Grifols Company Information
10.2.2 Grifols Introduction and Business Overview
10.2.3 Grifols Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Grifols Subcutaneous Immunoglobulins Products Offered
10.2.5 Grifols Recent Development
10.3 CSL
10.3.1 CSL Company Information
10.3.2 CSL Introduction and Business Overview
10.3.3 CSL Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2018-2023)
10.3.4 CSL Subcutaneous Immunoglobulins Products Offered
10.3.5 CSL Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Subcutaneous Immunoglobulins Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Subcutaneous Immunoglobulins Industrial Chain Analysis
11.4 Subcutaneous Immunoglobulins Market Dynamics
11.4.1 Subcutaneous Immunoglobulins Industry Trends
11.4.2 Subcutaneous Immunoglobulins Market Drivers
11.4.3 Subcutaneous Immunoglobulins Market Challenges
11.4.4 Subcutaneous Immunoglobulins Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Subcutaneous Immunoglobulins Distributors
12.3 Subcutaneous Immunoglobulins Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
